Literature DB >> 24979798

Dopamine transporters govern diurnal variation in extracellular dopamine tone.

Mark J Ferris1, Rodrigo A España2, Jason L Locke1, Joanne K Konstantopoulos1, Jamie H Rose1, Rong Chen1, Sara R Jones3.   

Abstract

The majority of neurotransmitter systems shows variations in state-dependent cell firing rates that are mechanistically linked to variations in extracellular levels, or tone, of their respective neurotransmitter. Diurnal variation in dopamine tone has also been demonstrated within the striatum, but this neurotransmitter is unique, in that variation in dopamine tone is likely not related to dopamine cell firing; this is largely because of the observation that midbrain dopamine neurons do not display diurnal fluctuations in firing rates. Therefore, we conducted a systematic investigation of possible mechanisms for the variation in extracellular dopamine tone. Using microdialysis and fast-scan cyclic voltammetry in rats, as well as wild-type and dopamine transporter (DAT) knock-out mice, we demonstrate that dopamine uptake through the DAT and the magnitude of subsecond dopamine release is inversely related to the magnitude of extracellular dopamine tone. We investigated dopamine metabolism, uptake, release, D2 autoreceptor sensitivity, and tyrosine hydroxylase expression and activity as mechanisms for this variation. Using this approach, we have pinpointed the DAT as a critical governor of diurnal variation in extracellular dopamine tone and, as a consequence, influencing the magnitude of electrically stimulated dopamine release. Understanding diurnal variation in dopamine tone is critical for understanding and treating the multitude of psychiatric disorders that originate from perturbations of the dopamine system.

Entities:  

Keywords:  caudate-putamen; circadian; nucleus accumbens

Mesh:

Substances:

Year:  2014        PMID: 24979798      PMCID: PMC4084435          DOI: 10.1073/pnas.1407935111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

1.  The GABA(B) agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure.

Authors:  K Brebner; W Froestl; M Andrews; R Phelan; D C Roberts
Journal:  Neuropharmacology       Date:  1999-11       Impact factor: 5.250

Review 2.  Genetic animal models: focus on schizophrenia.

Authors:  R R Gainetdinov; A R Mohn; M G Caron
Journal:  Trends Neurosci       Date:  2001-09       Impact factor: 13.837

3.  Regulation of dopamine quantal size in midbrain and hippocampal neurons.

Authors:  Emmanuel N Pothos
Journal:  Behav Brain Res       Date:  2002-03-10       Impact factor: 3.332

4.  Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep--wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats.

Authors:  I Léna; S Parrot; O Deschaux; S Muffat-Joly; V Sauvinet; B Renaud; M-F Suaud-Chagny; C Gottesmann
Journal:  J Neurosci Res       Date:  2005-09-15       Impact factor: 4.164

Review 5.  Current and emerging options for the drug treatment of narcolepsy.

Authors:  Alberto K De la Herrán-Arita; Fabio García-García
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

6.  Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry.

Authors:  Q Wu; M E Reith; R M Wightman; K T Kawagoe; P A Garris
Journal:  J Neurosci Methods       Date:  2001-12-15       Impact factor: 2.390

Review 7.  Modeling madness in mice: one piece at a time.

Authors:  P Alexander Arguello; Joseph A Gogos
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

8.  Dopaminergic role in stimulant-induced wakefulness.

Authors:  J P Wisor; S Nishino; I Sora; G H Uhl; E Mignot; D M Edgar
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

9.  Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.

Authors:  R R Gainetdinov; A R Mohn; L M Bohn; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

10.  Dopamine transporter density may be associated with the depressed affect in healthy subjects.

Authors:  Andrew Newberg; Jay Amsterdam; Justine Shults
Journal:  Nucl Med Commun       Date:  2007-01       Impact factor: 1.690

View more
  74 in total

Review 1.  Dopamine tunes prefrontal outputs to orchestrate aversive processing.

Authors:  Caitlin M Vander Weele; Cody A Siciliano; Kay M Tye
Journal:  Brain Res       Date:  2018-12-01       Impact factor: 3.252

2.  Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine.

Authors:  Zachary D Brodnik; Emily M Black; Meagan J Clark; Kristen N Kornsey; Nathaniel W Snyder; Rodrigo A España
Journal:  Neuropharmacology       Date:  2017-08-01       Impact factor: 5.250

3.  Voluntary ethanol intake predicts κ-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques.

Authors:  Cody A Siciliano; Erin S Calipari; Verginia C Cuzon Carlson; Christa M Helms; David M Lovinger; Kathleen A Grant; Sara R Jones
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

4.  Seeing how we smell.

Authors:  Helene Benveniste; Yuri Lazebnik; Nora D Volkow
Journal:  J Clin Invest       Date:  2017-01-23       Impact factor: 14.808

Review 5.  Circadian Rhythms and Substance Abuse: Chronobiological Considerations for the Treatment of Addiction.

Authors:  Ian C Webb
Journal:  Curr Psychiatry Rep       Date:  2017-02       Impact factor: 5.285

Review 6.  Dorsal striatum dopamine oscillations: Setting the pace of food anticipatory activity.

Authors:  Guillaume de Lartigue; Molly McDougle
Journal:  Acta Physiol (Oxf)       Date:  2018-06-27       Impact factor: 6.311

7.  Indirect pharmacodynamic models for responses with circadian removal.

Authors:  Vivaswath S Ayyar; Wojciech Krzyzanski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-01-29       Impact factor: 2.745

8.  Activation of the GABAergic Parafacial Zone Maintains Sleep and Counteracts the Wake-Promoting Action of the Psychostimulants Armodafinil and Caffeine.

Authors:  Christelle Anaclet; Kobi Griffith; Patrick M Fuller
Journal:  Neuropsychopharmacology       Date:  2017-07-19       Impact factor: 7.853

9.  Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.

Authors:  Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow
Journal:  Eur J Neurosci       Date:  2018-08       Impact factor: 3.386

10.  The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle.

Authors:  Jonathan Henry W Jacobsen; Femke T A Buisman-Pijlman; Sanam Mustafa; Kenner C Rice; Mark R Hutchinson
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.